Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Nuvalent (NUVL) posted Net Equity Issued and Repurchased of $10.14 million for Q1 2026, up 122.6% from $4.55 million a year earlier but down 98.0% from the prior quarter.

Analysis

Nuvalent (NUVL) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Net Equity Issued and Repurchased at Nuvalent was $521.3 million, down 8.2% year-over-year; for FY2025, it came in at $515.72 million, down 9.5% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 87.1% (FY2020 to FY2025).
  • In prior years, Nuvalent's Net Equity Issued and Repurchased was $569.99 million in FY2024 (+68.4%), $338.48 million in FY2023 (+35.1%), $250.47 million in FY2022 (+41.3%) and $177.27 million in FY2021 (+687.9%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of $13,000 in Q1 2022 to a high of $550.46 million in Q3 2024 over five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last six quarters, with growth averaging 14.8%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2024, with growth of 942.3%; the weakest was Q1 2022, with a decline of 99.9%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $500.64 million (Q4 2025), $4.77 million (Q3 2025) and $5.76 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Nuvalent 9.75 Bn 9.75 Bn - 10.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10.14 Mn
Dec 31, 2025 500.64 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 5.76 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 8.79 Mn
Sep 30, 2024 550.46 Mn
Jun 30, 2024 4.29 Mn
Mar 31, 2024 6.45 Mn
Dec 31, 2023 334.81 Mn
Sep 30, 2023 1.39 Mn
Jun 30, 2023 1.66 Mn
Mar 31, 2023 619,000.00
Dec 31, 2022 249.86 Mn
Sep 30, 2022 394,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 13,000.00
Sep 30, 2021 32.62 Mn
Jun 30, 2021 134.65 Mn
Mar 31, 2021 10.00 Mn
API Access

Nuvalent Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NUVL&period=max&api_key=YOUR_API_KEY